Although imaging studies (CT, MRI, etc.)and pathological analysis have become essential diagnostic tools for pancreatic cancer,4 recent research has increasingly recognized the potential of galectin-3 (Gal-3) as an effective early diagnostic molecular target.5 This evidence concerns the gene LGALS3 and pancreatic neoplasm.